Dr. Lakey is Professor Emeritus of Surgery and Biomedical Engineering at the University of California, Irvine, and a globally recognized researcher in translational science. He has authored more than 495 peer-reviewed scientific papers and contributed to over 45 book chapters. His depth of academic and clinical experience supports Symbiotic Systems’ mission to apply rigorous science to real-world impact.

Eric Mathur is a seasoned biotechnology innovator with experience spanning high-growth biotech companies and advanced genomics. He played key roles at Diversa Corporation during its IPO and later at Synthetic Genomics alongside Craig Venter. As a named inventor on more than 100 patents, Eric brings deep expertise in commercializing breakthrough biological technologies.

David D’Arcangelo is an experienced corporate strategist specializing in restructuring, growth optimization, and value creation for public and private companies. With a proven track record of driving revenue and profitability, he advises Symbiotic Systems on scaling strategy, operational efficiency, and long-term business performance.